Last updated on January 2017

Evaluation of the Ease of Use Preference and Safety of EutropinPen Inj.


Brief description of study

The purpose of this study is to assess the ease of use, preference, and safety after 8 weeks subcutaneous administration of EutropinPen Inj. in patients pretreated with recombinant human growth hormone by reusable device.

Clinical Study Identifier: NCT03015909

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Yeon Kim, MS

Ajou university hospital
Suwon, Korea, Republic of
  Connect »